NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1831240704 M.D.
Verify on CMS → Ilya Rozenbaum, M.D.
Ophthalmology Physician in Pennington, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 792 beneficiaries · Ophthalmology Physician avg: 1K
MIPS score
90.9/100
▲ 7 pts above national avg 83.5 · Exceptional
Industry payments
$354.21
9 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Ilya Rozenbaum, M.D. reported a CMS MIPS final score of 90.9/100 - above the 83.5 national average - and filed 4,479 Medicare Part D claims in 2023.
- 90.9/100
- MIPS score · +7 vs avg
- 4K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
- ≥58th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Ilya Rozenbaum, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1831240704), first enumerated 01/16/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 4,479 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 90.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$354.21 in reported industry payments (9 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1831240704 · Ophthalmology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1831240704
- ENUM-MID 2007
- TAX-MID 22K Ophthalmology Physician
- MIPS-ABOVE 90.9/100
- RX-MID 4,479
- BOOK-LIGHT 629 in New Jersey
- PHOTO-FINISH Evan Chang · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Rozenbaum · this…
Rozenbaum · this provider
90.9 MIPS pts
- Jeffrey Caspar ·…
Jeffrey Caspar
90.9 MIPS pts
- Evan Chang · near
Evan Chang
90.9 MIPS pts
- Cathy Zhang · near
Cathy Zhang
90.9 MIPS pts
- James Brandt · n…
James Brandt
90.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Ilya Rozenbaum, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 58th percentile 58% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ilya Rozenbaum, M.D. sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ilya Rozenbaum, M.D. writes more Part D claims than 94% of them and scores higher on MIPS quality than 54% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Ilya Rozenbaum, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Ilya Rozenbaum, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ilya Rozenbaum, M.D.?
High performer (top quartile)Primary specialty
Ophthalmology Physician
Medicare Part D claims
4,479 215% vs specialty avg
MIPS final score
90.9/100 7.4 pts vs avg
Specialty distribution in New Jersey
How Ophthalmology Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Ilya Rozenbaum, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 90.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1831240704 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 01/16/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
90.9195
Final Score
Measured-score avg: 83.5
99.4303
Quality
70.776
Cost
Reporting: Group practice
Hospital and facility affiliations
Facilities where Ilya Rozenbaum, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Associated Retinal Consultants LLC
Pennington, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ilya Rozenbaum, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$354
Largest payer
Bausch & Lomb Americas Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,479
Total Claims
$914K
Total Drug Cost
792
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,699
- Total Day Supply
- 251,607
- Generic Drug Cost
- $156K
Patient Demographics
- Average Patient Age
- 76.9 years
- Avg HCC Risk Score
- 1.20
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 27, 65-74: 308, 75-84: 300, 85+: 157
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ilya Rozenbaum, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
1,469 claims
- Dorzolamide-Timolol 342
Dorzolamide-Timolol
342 claims
- Timolol Maleate 292
Timolol Maleate
292 claims
- Lumigan 278
Lumigan
278 claims
- Combigan 207
Combigan
207 claims
- Prednisolone Acetate 203
Prednisolone Acetate
203 claims
- Dorzolamide Hcl 157
Dorzolamide Hcl
157 claims
- Alphagan P 155
Alphagan P
155 claims
| Drug | Claims |
|---|---|
| Latanoprost | 1,469 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 342 |
| Timolol Maleate | 292 |
| Lumigan Bimatoprost | 278 |
| Combigan Brimonidine Tartrate/Timolol | 207 |
| Prednisolone Acetate | 203 |
| Dorzolamide Hcl | 157 |
| Alphagan P Brimonidine Tartrate | 155 |
| Rhopressa Netarsudil Mesylate | 140 |
| Brimonidine Tartrate | 132 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Ilya Rozenbaum, M.D. fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Ilya Rozenbaum, M.D.'s 4,479 claims are above the specialty average of 1,420.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Rozenbaum, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (90.9 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Rozenbaum.
One of 629 Ophthalmology Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Bryan Abessi
M.D.
Branchburg, NJ
Dr. Atul Agarwala
MD
Irvington, NJ
Dr. Arlene Ahmad
MD
Boonton, NJ
Dr. Adil Ahmed
DO
Brick, NJ
Dr. Scott Aksman
MD
Freehold, NJ
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ilya Rozenbaum, M.D.'s specialty? ▼
Ilya Rozenbaum, M.D. specializes in Ophthalmology Physician and practices in Pennington, New Jersey. Credentials: M.D..
How much does Ilya Rozenbaum, M.D. prescribe under Medicare Part D? ▼
In 2023, Ilya Rozenbaum, M.D. wrote 4,479 Medicare Part D claims totaling $914K in drug costs for 792 beneficiaries.
What is Ilya Rozenbaum, M.D.'s Medicare quality score? ▼
Ilya Rozenbaum, M.D. has a CMS MIPS Final Score of 90.9/100 (Quality: 99.4, Cost: 70.8). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ilya Rozenbaum, M.D. located? ▼
Ilya Rozenbaum, M.D. is located at 2 CAPITAL WAY, Pennington, NJ, 08534. Phone: (609) 882-8833.
What is Ilya Rozenbaum, M.D.'s NPI number? ▼
Ilya Rozenbaum, M.D.'s National Provider Identifier (NPI) is 1831240704, issued on 01/16/2007.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Ilya Rozenbaum, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Ilya Rozenbaum, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ilya Rozenbaum, M.D. accept Medicare? ▼
Ilya Rozenbaum, M.D. appears in CMS Medicare data with 4,479 Part D claims and 792 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ilya Rozenbaum, M.D.'s credentials? ▼
Ilya Rozenbaum, M.D.'s NPI is 1831240704 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.